Completed PHASE4 INTERVENTIONAL 2-arm NCT01608347

Low Molecular Weight Heparin in Recurrent Miscarriage With Negative Antiphospholipid Antibodies (LMWH-APAN)

Low Molecular Weight Heparin for Treatment of Recurrent Miscarriage With Negative Antiphospholipid Antibodies: a Randomized Controlled Trial

Sponsor: Omar Mamdouh Shaaban

Conditions Recurrent Miscarriage

Interventions Folic Acid LMWH+Folic acid

Updated 6 times since 2017 Last updated: Jan 23, 2017 Started: Jan 31, 2010 Primary completion: Sep 30, 2012 Completion: Dec 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01608347, this PHASE4 trial focuses on Recurrent Miscarriage and remains completed. Sponsored by Omar Mamdouh Shaaban, it has been updated 6 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4

Status: Unknown Status → Completed

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Unknown Status PHASE4

First recorded

Jan 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Omar Mamdouh Shaaban

Data source: Assiut University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.